During infection with gram-negative bacteria, exposure of immune cells to l
ipopolysaccharide (LPS) from the bacterial cell membrane induces a rapid cy
tokine response which is essential for the activation of host defenses agai
nst the invading pathogens. Administration of LPS to mice induces a state o
f hyporesponsiveness, or tolerance, characterized by reduced cytokine produ
ction upon subsequent LPS challenge. In the model of experimental Salmonell
a enterica serovar Typhimurium infection of mice, we assessed the question
of whether complete LPS tolerance induced by repetitive doses of LPS interf
ered with cytokine production and host defense against gram-negative bacter
ia. Although production of various cytokines in response to serovar Typhimu
rium was attenuated by LPS pretreatment, LPS-tolerant mice showed improved
antibacterial activity, evidenced by a prolongation of survival and a conti
nuously lower bacterial load. We attribute this protective effect to three
independent mechanisms. (i) Peritoneal accumulation of leukocytes in the co
urse of LPS pretreatment accounted for enhanced defense against serovar Typ
himurium during the first 6 h of infection but not for decreased bacterial
load in late-stage infection. (iii) LPS-tolerant mice had an increased capa
city to recruit neutrophilic granulocytes during infection. (iii) LPS-toler
ant mice showed threefold-increased Kupffer cell numbers, enhanced phagocyt
ic activity of the liver, and strongly improved clearance of blood-borne se
rovar Typhimurium. These results demonstrate that despite attenuated cytoki
ne response, acquired LPS tolerance is associated with enhanced resistance
to infections by gram-negative bacteria and that this effect is mainly medi
ated by improved effector functions of the innate immune system.